Mapping cognitive impairment in outpatient neurology patients
PAMNEU: Easy Detection of Memory Disorders Using Very Short ALBA and PICNIR Tests in Neurological Outpatient Clinics in the Czech Republic
This study is testing how common cognitive problems are in patients visiting neurology clinics in the Czech Republic and whether certain tests can help find these issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Charles University, Czech Republic Academic / other |
| Locations | 1 site (Praha) |
| Trial ID | NCT06154564 on ClinicalTrials.gov |
What this trial studies
The PAMNEU project aims to assess the distribution and severity of cognitive impairment among patients attending outpatient neurologic offices in the Czech Republic. A total of 1000 patients will undergo cognitive testing using the ALBA and PICNIR methods, along with psychometric scales like FAQ-CZ and GDS-CZ to evaluate their functional state and depressive symptoms. The study's primary goal is to identify the prevalence of cognitive impairment across different diagnostic groups according to ICD-10 and to evaluate the effectiveness of the testing methods in uncovering undiagnosed cognitive issues.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50 and older with a neurological diagnosis and at least six months of follow-up in an outpatient setting.
Not a fit: Patients with mental retardation, significant sensory impairments, or those unable to participate due to physical limitations will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and diagnosis of cognitive impairment in neurology, leading to better patient management.
How similar studies have performed: While similar studies have been conducted, this specific approach to mapping cognitive impairment in outpatient settings is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Dispensarization of at least six months in an outpatient neurologic office with an ICD-10 diagnosis * Age\>=50 * Permanent residency in the geographical area of the Czech Republic Exclusion Criteria: * Diagnosis of mental retardation (F70-F79) according to ICD-10 * Refusal to sign the informed consent and consent with GDPR * Uncorrected visual impairment * Uncorrected auditory impairment * Impairment of hand movement preventing the patient from filling in the questionnaires. * Inability to participate in the project
Where this trial is running
Praha
- Teaching Hospital Královské Vinohrady — Praha, Czechia (Recruiting)
Study contacts
- Principal investigator: Aleš Bartoš, M.D., Ph.D. — Charles University, Czech Republic
- Study coordinator: Aleš Bartoš, M.D., Ph.D.
- Email: ales.bartos@fnkv.cz
- Phone: 00420267162297
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.